Public research university in London, United Kingdom
POPULARITY
Categories
Autoimmune Rehab: Autoimmune Healing, Support for Autoimmune Disorders, Autoimmune Pain Relief
Fibromyalgia pain can be relentless—impacting sleep, energy, mood, and daily life. In this powerful episode, we sit down with Sheri Emami, a health coach and former fibromyalgia patient who specializes in helping people manage and reduce fibromyalgia pain naturally. You'll discover the latest insights into what triggers flare-ups, how to address underlying inflammation, and practical strategies for reclaiming your quality of life. Whether you've been newly diagnosed or have been living with fibromyalgia pain for years, this conversation offers actionable tips, mindset shifts, and resources to help you feel empowered in your healing journey. Listen in to learn: What causes fibromyalgia pain and why it's so complex The role of nutrition, movement, and stress management in symptom relief Simple daily habits that can reduce flare-ups How to create a personalized plan for long-term wellness If you or someone you love is struggling with fibromyalgia pain, you won't want to miss this episode. Shari Emami, HHP, C.H.C., is an AADP board-certified holistic health practitioner and Certified Health Coach passionate about fibromyalgia and chronic illness recovery. With training from Harvard Medical School's CHEF Coaching Basics program, Imperial College London's Health Coaching Conversations course, and the Dr. Sears Wellness Institute, she delivers evidence-based culinary coaching and holistic wellness solutions. Pain-free since 2016, Shari's award-winning book, “Breaking Free From Pain”, has inspired others on many on ways of naturally healing fibromyalgia. She has spoken and given lectures at both universities and libraries. Book- Breaking Free From Pain: https://www.amazon.com/dp/B0CYY5PHXZ Video interview: https://readershouse.co.uk/shari-emami-shares-her-journey-of-healing-and-holistic-living-in-breaking-free-from-pain/ Website for this podcast: http://autoimmunerehab.com
Send us a textSubstance use disorder affects millions, yet less than 10% receive treatment. In this episode of CareTalk, John Driscoll speaks with Dr. Yusuf Sherwani, CEO and Co-Founder of Pelago, about a new approach to addiction care. They explore how Pelago is using virtual treatment, data, and value-based care to break down barriers like stigma, access, and cost—reshaping how we treat one of healthcare's most persistent challenges.
Dr. Leor Roseman, Senior Lecturer and Psychedelic Researcher at the University of Exeter, has explore this avenue. His study “Relational Processes in Ayahuasca Groups of Palestinians and Israelis” a few years ago, was fascinating.I read about it in 2021, (https://pmc.ncbi.nlm.nih.gov/articles/PMC8170481/) and we recorded the first podcast. To me the idea made a lot of sense. Now, with the urgency amid the current situation after October 7th, his work seems more important than ever. In his scientific work Leor examines how psychedelics can serve as peacemaking tools by altering consciousness through a biopsychosocial lens, incorporating neuroscience, psychology, anthropology, and phenom enology. With a background at the Centre for Psychedelic Research at Imperial College London, under Prof. Robin Carhart-Harris and Prof. David Nutt, Leor was curious how psychedelics now can deliver a new peacemaking tool. His foundation Ripples, a non-profit dedicated to peace building supported by psychedelics, is now researching new ideas around understanding, without ignoring the actual conflict. The urgency right now is on the Israel and Palestine Conflict. But his work can be valid for other conflicted parties too. Hosted on Acast. See acast.com/privacy for more information.
Proudly sponsored by PyMC Labs, the Bayesian Consultancy. Book a call, or get in touch!Intro to Bayes Course (first 2 lessons free)Advanced Regression Course (first 2 lessons free)Our theme music is « Good Bayesian », by Baba Brinkman (feat MC Lars and Mega Ran). Check out his awesome work!Visit our Patreon page to unlock exclusive Bayesian swag ;)Takeaways:Bayesian deep learning is a growing field with many challenges.Current research focuses on applying Bayesian methods to neural networks.Diffusion methods are emerging as a new approach for uncertainty quantification.The integration of machine learning tools into Bayesian models is a key area of research.The complexity of Bayesian neural networks poses significant computational challenges.Future research will focus on improving methods for uncertainty quantification. Generalized Bayesian inference offers a more robust approach to uncertainty.Uncertainty quantification is crucial in fields like medicine and epidemiology.Detecting out-of-distribution examples is essential for model reliability.Exploration-exploitation trade-off is vital in reinforcement learning.Marginal likelihood can be misleading for model selection.The integration of Bayesian methods in LLMs presents unique challenges.Chapters:00:00 Introduction to Bayesian Deep Learning03:12 Panelist Introductions and Backgrounds10:37 Current Research and Challenges in Bayesian Deep Learning18:04 Contrasting Approaches: Bayesian vs. Machine Learning26:09 Tools and Techniques for Bayesian Deep Learning31:18 Innovative Methods in Uncertainty Quantification36:23 Generalized Bayesian Inference and Its Implications41:38 Robust Bayesian Inference and Gaussian Processes44:24 Software Development in Bayesian Statistics46:51 Understanding Uncertainty in Language Models50:03 Hallucinations in Language Models53:48 Bayesian Neural Networks vs Traditional Neural Networks58:00 Challenges with Likelihood Assumptions01:01:22 Practical Applications of Uncertainty Quantification01:04:33 Meta Decision-Making with Uncertainty01:06:50 Exploring Bayesian Priors in Neural Networks01:09:17 Model Complexity and Data Signal01:12:10 Marginal Likelihood and Model Selection01:15:03 Implementing Bayesian Methods in LLMs01:19:21 Out-of-Distribution Detection in LLMsThank you to my Patrons for making this episode possible!Yusuke Saito, Avi Bryant, Ero Carrera, Giuliano Cruz, James Wade, Tradd Salvo, William Benton, James Ahloy, Robin Taylor,, Chad Scherrer,...
La científica Michele Dougherty hace historia como la primera mujer Astrónoma Real del Reino Unido Por Félix Riaño @LocutorCo La física espacial Michele Dougherty ha sido nombrada la primera Astrónoma Real en 350 años. Su trabajo reveló indicios de vida en una luna de Saturno. El Reino Unido acaba de nombrar, por primera vez en tres siglos y medio, a una mujer como Astrónoma Real. La profesora Michele Dougherty, nacida en Sudáfrica y actual experta en física espacial del Imperial College London, fue quien lideró investigaciones que descubrieron géiseres de agua en Encelado, una de las lunas de Saturno. Ese hallazgo hizo pensar a la comunidad científica que podría haber vida en ese lugar. Además, dirige instrumentos a bordo de la sonda JUICE, rumbo a las lunas heladas de Júpiter.¿Qué significa su nombramiento en un cargo históricamente reservado a hombres blancos? Nunca estudió ciencias en el colegio, ni pensaba hacerlo. Michele Dougherty nació en Sudáfrica, en una familia con herencia inglesa e irlandesa. Cuando tenía 10 años, su padre construyó un telescopio en el jardín. Ella y su hermana ayudaron a mezclar el cemento de la base. A través de ese telescopio vio por primera vez los anillos de Saturno y las lunas de Júpiter. Pero, en esa época, ni siquiera pensaba dedicarse a la ciencia. En su adolescencia eligió un colegio donde no enseñaban física ni química, solo por estar con sus amigas. Aun así, era muy buena en matemáticas. Por eso, más adelante, fue admitida en una universidad para estudiar ciencias. Aprendió desde cero, con esfuerzo y constancia, hasta convertirse en una de las científicas más importantes del Reino Unido. Durante siglos, la ciencia fue un mundo cerrado para muchas personas. El cargo de Astrónomo Real se creó en 1675, cuando el rey Carlos II de Inglaterra inauguró el Observatorio Real de Greenwich. Desde entonces, 15 hombres lo habían ocupado. Nunca una mujer. Y mucho menos alguien que, de niña, no estudió ciencia en el colegio. Michele Dougherty rompió esa barrera, pero su propio deseo es que el reconocimiento no sea solo por ser mujer, sino por lo que ha logrado. Su trabajo en la sonda Cassini descubrió chorros de agua saliendo de Encelado, indicando actividad geológica y condiciones que podrían albergar vida. También lidera el magnetómetro de la misión JUICE, que va a estudiar Ganimedes, la luna más grande del sistema solar. Dougherty teme que la financiación de la ciencia se vea afectada por inestabilidad política y económica. Por eso, quiere usar este cargo para hablar con la gente sobre por qué la ciencia importa. Como Astrónoma Real, Dougherty no manejará el observatorio ni trazará rutas marítimas usando las estrellas, como en el siglo XVII. El cargo se volvió honorífico desde 1972. Pero sí tendrá una función pública: inspirar, explicar, comunicar la importancia de la astronomía. “Quiero entusiasmar al público y hacerles ver que la astronomía afecta nuestra vida diaria”, dijo en una entrevista. Su nombramiento coincide con un cambio cultural en la ciencia británica. Desde 2021, Catherine Heymans ya ocupaba el cargo de Astrónoma Real de Escocia, y ahora ambas representan a todo el Reino Unido. Dougherty es también presidenta electa del Instituto de Física, profesora en Imperial College y presidenta del Consejo de Infraestructura Científica del Reino Unido. En todos esos roles, su mensaje es claro: la ciencia debe abrirse, debe explicarse, y debe entusiasmar a los niños y niñas que nunca se vieron a sí mismos como científicos. La sonda Cassini, de la NASA, operó desde 1997 hasta 2017. Dougherty se unió al proyecto en 1992, como investigadora del instrumento de campo magnético. En 2005, notó una pequeña anomalía en los datos cuando Cassini sobrevoló Encelado. Insistió en volver a pasar cerca del polo sur de la luna, a pesar de las dudas de los líderes del proyecto. Y acertó: descubrieron un chorro de vapor de agua. Ese hallazgo cambió la visión que teníamos sobre las lunas heladas del sistema solar. Desde entonces, Encelado se considera uno de los lugares más prometedores para buscar vida. Ahora, su nuevo proyecto es JUICE, una misión de la Agencia Espacial Europea lanzada en 2023, que llegará a Júpiter en 2031. La nave estudiará si Ganimedes tiene un océano bajo su superficie. Dougherty diseñó el magnetómetro que viajará a bordo. La ciencia que lidera desde Londres está cambiando lo que sabemos sobre el sistema solar. Michele Dougherty fue nombrada Astrónoma Real del Reino Unido, tras 350 años de historia masculina. Su trabajo sobre Encelado y Ganimedes transformó la exploración espacial.Sigue más historias como esta en el pódcast Flash Diario en Spotify. Michele Dougherty, pionera en misiones a Saturno y Júpiter, es la primera Astrónoma Real en 350 años.
Today, a massive 8.8 magnitude earthquake off Russia's far eastern coast has triggered tsunami warnings across the Pacific.The quake struck near Russia's Kamchatka Peninsula at about 11:25am local time on Wednesday (00:25 BST) and is thought to be one of the most powerful ever recorded. Around two million people were ordered to evacuate in Japan, Russia, and Hawaii - although many of those warnings have since been downgraded.Joining Adam live from Tokyo is Shaimaa Khalil, the BBC's Tokyo Correspondent, with the latest on the situation in Japan.Adam also speaks to Dr Rebecca Bell, Associate Professor in Tectonics at Imperial College London, and BBC Science Correspondent Victoria Gill.You can now listen to Newscast on a smart speaker. If you want to listen, just say "Ask BBC Sounds to play Newscast”. It works on most smart speakers. You can join our Newscast online community here: https://tinyurl.com/newscastcommunityhereGet in touch with Newscast by emailing newscast@bbc.co.uk or send us a whatsapp on +44 0330 123 9480.New episodes released every day. If you're in the UK, for more News and Current Affairs podcasts from the BBC, listen on BBC Sounds: https://bit.ly/3ENLcS1 Newscast brings you daily analysis of the latest political news stories from the BBC. It was presented by Adam Fleming. It was made by Jack Maclaren with Gabriel May and Kris Jalowiecki. The social producer was Sophie Millward. The technical producer was Hannah Montgomery. The assistant editor is Chris Gray. The senior news editor is Sam Bonham.
Bruken av psykedeliske stoffer i terapeutiske sammenhenger er ikke ny. På 1950- og 1960-tallet ble LSD og psilocybin brukt eksperimentelt i psykoterapi, med varierende suksess. Etter en periode med forbud og stigmatisering, har nyere forskning og kliniske studier gjenopplivet interessen for disse stoffene. Studier ledet av forskere som Roland Griffiths ved Johns Hopkins University og Robin Carhart-Harris ved Imperial College London har dokumentert positive effekter av psilocybin-assistert terapi for behandling av depresjon og angst, spesielt hos pasienter med livstruende kreftdiagnoser. Studiene ramler inn fra ulike hold, og stemningen hos behandlere i psykisk helsevern er todelt. Noen er ekstremt skeptiske, mens andre er svært håpefulle. Jeg befinner meg på et seminar i regi av Sørlandet sykehus hvor forskere på feltet snakker om tall og effekt-størrelser fra sine studier. Det gir tyngde til psykedelika assistert terapi, men jeg synes tall er litt kjedelig. Min oppgave denne dagen var å snakke litt mer løst og lettbeint om klinikernes tanker om psykedelika i behandling. Siden jeg var litt lei av tall og detaljerte mål på effekt, ønsket jeg å snakke litt mer og forholdet mellom terapi og de erfaringene man får under påvirkning av psykedeliske stoffer. Jeg synes det er interessant at opplevelsen mange rapporterer har en slags drømmeaktig logikk, og sånn sett ser jeg for meg at jungianere og psykoanalytikere kan komme til sin rett når det gjelder å integrere, avkode, forstå og gi mening til de opplevelsene mange får på psykedeliske stoffer. Det betyr at forskere som er opptatt av tall og evidens må snakke med terapeuter som er opptatt av drømmer og det symbolske mennesket. Det er to avdelinger innenfor psykisk helse som normalt sett ikke snakker så godt sammen, og derfor oppleves introduksjonen av psykedelika i behandling som en slags venners venner fest hvor mange av gjestene i utgangspunktet ikke kan fordra hverandre. Og det var litt den stemningen jeg plukket opp på Sørlandet Sykehus 20 juni 2024. Nå skal du få være med til mitt korte innlegg, hvor jeg stotrer og snakker i halvsetninger om mitt skråfaglige perspektiv på psykedlika. Vil du ha mer psykologi og flere dypdykk i menneskets sjelsliv? Bli medlem på vårt Mentale Helsestudio.Last ned SinSyn-appen på www.sinnsyn.no/download/ Eller meld deg inn via www.patron.com/sinsyn Hosted on Acast. See acast.com/privacy for more information.
In this episode, host Jonathan Sackier is joined by Steven Okoli, Honorary Senior Clinical Lecturer at Imperial College London. From leading the UK's first adult stem cell transplant trial for sickle cell disease to driving innovation in AI-guided transfusion strategies, Okoli shares how clinical research, patient advocacy, and equity-driven care are reshaping the landscape of haemoglobinopathies in the UK and beyond. Timestamps 00:00: Introduction 01:58: Quickfire round 09:09: Pioneering adult stem cell transplant in sickle cell 11:41: Combining AI and genetics for blood transfusion 13:58: Systemic disparities in sickle cell 20:58: Education and advocacy 23:30: Non-cancerous blood disorders 25:18: What's next in sickle cell? 27:27: Okoli's three wishes for healthcare
Can bioregualtory peptides slow biological aging? What are bioregulatory peptides and how do they work? Is this the next big thing in anti-aging medicine? I had the pleasure to sit down with Dr Rob Verkerk at the Integrative and Personalised Medicine Congress in London to talk all things Bioregulatory peptides. These are molecules which have huge promise in the regenerative medicine space. I was hugely excited to hear more about them and the potential they have to regenerate and heal tissue more effectively. We cover: The science behind bioregulatory peptides What they are and how they can be used The most compelling research in this field Access to bioregulatory peptides And much more Dr Rob Verkerk has Masters and Doctorate degrees from Imperial College London and in 2002 founded the Alliance for Natural Health International. Since then, Rob has acted as its executive and scientific director, directing legal actions to protect the right to natural health, whilst authoring some 60 papers in scientific journals and conference proceedings. https://www.anhinternational.org https://www.anhinternational.org/news/miracle-molecules-that-reverse-biological-age/
When you imagine a scientific conference, you may picture rows of poster boards, bustling coffee breaks, and seasoned researchers discussing the latest data and research approaches. It can feel like a world reserved for insiders. Yet a recent study led by Dr Malgorzata Trela and Dr Sophie Rutschmann at Imperial College London argues that this lively professional gathering is precisely where tomorrow's scientists ought to cut their teeth. Their paper, “Immunology in Practice: a modular framework to support Master of Science students' conference attendance and engagement,” describes an educational project that turns a four-day professional congress into the beating heart of a master's-level module, and in doing so, reshapes how students learn, network and even see themselves.
On this episode of Trending in Education, Mike Palmer is joined by Elliot Felix, a returning guest, to discuss his new book, The Connected College: Leadership Strategies for Student Success. The book, releasing July 22nd, focuses on how higher education can become more agile, connected, and break down silos. Elliot Felix shares his mission of student success, drawing on his experience consulting with over 120 colleges and universities to improve student experiences through transformations in physical spaces, support services, and technology systems. He explains that his new book aims to provide an evidence-based playbook for higher education professionals to collaborate better for student success. Key Takeaways: Addressing Disconnections in Higher Ed: Felix identifies five key disconnections the book addresses, including a lack of belonging among students (only 65% feel they belong), the disconnect between courses and careers, and the prevalence of siloed structures within institutions. He illustrates this with an example of a university having both a "writing lab" and a "writing center" performing similar functions due to historical and structural reasons. The Connected College Vision: Felix envisions a future where colleges and universities are better connected, leading to students feeling a stronger connection to their institution, their coursework linking to careers, and increased collaboration both internally and with external partners like corporations and community groups. Defining Student Success: The conversation delves into the multifaceted definition of student success, acknowledging that it can be viewed through metrics like retention and graduation rates, student engagement and belonging, or the individual student's perspective of success. Felix suggests common ground for student success includes students finding their community, their academic and career path, their place, and a sense of purpose. Silo Busting Strategies: Felix highlights that silos are common in organizations, particularly in higher education, which is designed for durability. He attributes this to a lack of clear strategy beyond broad, anodyne statements, and legacy structures that simply have new functions "bolted on" rather than integrated. Tactics for breaking down silos include sharing data to create a common understanding of students. Forward-Thinking Universities: Examples of innovative approaches include university-industry partnerships driving economic and workforce development, such as Carnegie Mellon's robotics innovation center and Rowan University's expansion into health and wellness and advanced manufacturing. Other examples include Imperial College London's enterprise lab, the University of South Florida's focus on entrepreneurship, and Arizona State's "Work Plus Learn" program. Don't miss Elliot's new book, The Connected College: Leadership Strategies for Student Success, available July 22nd wherever you get your books. Subscribe to Trending in Ed so you never miss a conversation about leading the future of education in these transformative times. 00:00 Introduction and Guest Welcome 01:07 Elliot Felix's Background and Mission 02:26 The Connected College: Themes and Issues 06:28 Book Structure and Innovator Profiles 07:54 Defining Student Success 13:23 Silo Busting in Higher Education 17:14 AI and Future Trends in Higher Ed 20:36 The Importance of Combining Skills in Higher Education 21:06 Collaborative Spirit in Developing AI Policies 22:26 Navigating Political and Technological Disruptions 31:15 The Role of Higher Education in Economic Development 31:43 Innovative University-Industry Partnerships 33:08 Spotlighting Success Stories in Higher Education 35:49 Concluding Thoughts and Future Directions
TopMedTalk's Andy Cumpstey continues our coverage of the hugely successful Evidence-Based Perioperative Medicine (EPBOM) World Congress in London. Here we dive deep into the realm of patient monitoring, exploring the use of wearable sensors and advanced algorithms for early detection and preventive care in hospital environments. Learn about ongoing research, innovation challenges, and prospective trials aiming to enhance patient care and safety. A comprehensive discussion on the future of healthcare technology and its implications on clinical practice. Presented by Andy Cumpstey with his guests, Sadia Khan, Consultant Cardiologist at West Middlesex University Hospital, Meera Joshi, Specialist registrar at Ashford and St Peter's Hospital NHS Foundation Trust and clinical research fellow in the department of surgery cancer at Imperial College London and Jasjit Syan, Senior Clinical Fellow in Cardiology and a PhD candidate in Digital Health at Chelsea and Westminster NHS Foundation Trust.
In this episode of The Psychedelic Podcast, Paul F. Austin is joined by renowned neuroscientist Dr. Robin Carhart-Harris and microdosing policy advocate John Downs for a replay of a live event originally held on June 10th, Microdosing vs. SSRIs: What's Happening in the Brain and Why It Matters. Find full show notes and links here: https://thethirdwave.co/podcast/episode-312b/?ref=278 Together, they explore the scientific distinctions between SSRIs and psychedelics, focusing on neuroimaging, brain entropy, emotional processing, and the REBUS model. Dr. Carhart-Harris shares key insights from landmark studies on psilocybin therapy and discusses the evidence (and limitations) around microdosing. John Downs closes the conversation with an update on the Microdosing Collective's efforts to shift policy and expand access. Robin Carhart-Harris, PhD is a neuropharmacologist, psychologist, and Ralph Metzner Distinguished Professor in Neurology and Psychiatry at the University of California, San Francisco. He leads the Psychedelics Division at UCSF's Neuroscape and formerly founded and led the Centre for Psychedelic Research at Imperial College London. John Downs is Executive Director of the Microdosing Collective, advocating for responsible policy reform and legal access to microdosing. With 25 years' experience in sales, business development, and emerging markets, John helps individuals optimize mindset, performance, and purpose. Episode Highlights: Why SSRIs blunt, while psychedelics reset emotional processing How psilocybin compares to antidepressants in clinical trials Brain entropy, plasticity, and the REBUS model explained The role of the default mode network in mental health Why microdosing research is still so limited Ketamine vs. psilocybin: differences in brain mechanisms Is serotonin syndrome a real microdosing risk? Can psychedelics reverse long-term SSRI effects? The Microdosing Collective's mission for policy reform What Robin Carhart-Harris' upcoming book will explore Episode Links: Robin's lab & upcoming book Microdosing Collective Join Dr. Robin Carhart-Harris at our Practitioner Intensive (November 5–10, Costa Rica) Episode Sponsors: Golden Rule Mushrooms - Get a lifetime discount of 10% with code THIRDWAVE at checkout Psychedelic Coacing Isntitute's Intensive for Psychedelic Professionals in Costa Rica - a transformative retreat for personal and professional growth.
As a new warning is released by scientists that trying to offset our carbon emissions by planting trees alone won't work, we investigate the role the Earth's forests are playing in the fight against climate change.Marnie Chesterton is joined by Mark Maslin, Professor of Earth System Science at University College London, to help answer our top five questions about trees and CO2. We also speak to science writer and New York Times columnist Carl Zimmer about his new book ‘Air-Borne: The Hidden History of the Life We Breathe', and what it tells us about what we're breathing into our lungs each day. After we reported on the plight of some of our UK wild bird species earlier this year, many listeners got in touch wanting to know more about one species in particular: house sparrows. To look at why their numbers have been declining so sharply, and what we might be able to do about it, we hear from Imperial College London's Dr Julia Schroeder, who has been studying the birds for 15 years.And Marnie is joined in the studio by Lizzie Gibney, Senior Reporter at Nature, to explore some of the fascinating research from around the world in this week's science journals.Presenter: Marnie Chesterton Producers: Clare Salisbury, Dan Welsh and Jonathan Blackwell Editor: Martin Smith Production Co-ordinator: Jana Bennett-Holesworth
In this episode, I'm joined by Tommaso Barba from Imperial College London to explore how psychedelics are transforming mental health research. We break down what these compounds are, how they work in the brain, and why they offer hope for conditions like depression, anxiety, OCD, and addiction. Tommaso also shares insights on the future of psychedelic therapy — and the importance of safety, integration, and realistic expectations.Find Tommaso:Instagram: @tommaso.barbaWork: https://profiles.imperial.ac.uk/tommaso.barba20LinkedIn: https://www.linkedin.com/in/tommaso-barba-88220a177/?originalSubdomain=ukStay Connected with Hurt to Healing:Instagram: instagram.com/hurttohealingpodTikTok: tiktok.com/@hurttohealingpodLinkedIn: linkedin.com/company/hurt-to-healingSubstack: substack.com/@hurttohealingWebsite: hurttohealing.co.uk Hosted on Acast. See acast.com/privacy for more information.
Scientists in the UK want to send a tiny space probe to Venus to search for signs of life in its clouds. Imperial College London's Dave Clements spoke to Corin Dann.
There is an experience some of us (but not all) are able to have called autonomous sensory meridian response or ASMR. It can be triggered by a soft monotonous voice explaining something as well as other triggers. Sounds weird, right? Listen as I explain how it works, why science doesn't recognize it as a real thing but for many of us, it is a wonderful sensation, and I will tell you how to experience it. https://www.mentalfloss.com/article/53220/listening-soft-voices-can-cause-brain-orgasms The YouTube video link mentioned is: https://www.youtube.com/watch?v=CHiKxytbCWk Difficult conversations are never fun, but they are necessary. Whether you are negotiating for a raise or having a tough conversation with your spouse or friend, there are ways to make these conversations go better for you and everyone involved. Here to offer some expertise on this is Ryan Dunlap a former police detective and hostage negotiator. He has been involved in a lot of high stakes negotiations in his career and he is author of the book How to Untie a Balloon: A Negotiator's Guide to Avoid Popping Under Pressure (https://amzn.to/3Ia2c72) What are the best practices for living a long and healthy life? There are many theories on this but here to discuss the science of longevity is John Tregoning who explains that living a long life may best be accomplished by living a good life. John is Professor of Vaccine Immunology at Imperial College London and has published over sixty academic papers. He is author of the book, Live Forever?: A Curious Scientist's Guide to Wellness, Ageing and Death (https://amzn.to/4kc9B2J). How do you write a good business email? Interestingly, there are some common mistakes people make that water down the message in business emails by making them sound more like personal emails. Listen as I reveal how to avoid that. https://www.inc.com/geoffrey-james/7-common-habits-that-kill-credibility.html#ixzz3c6aUXNnN PLEASE SUPPORT OUR SPONSORS!!! SHOPIFY: Shopify is the commerce platform for millions of businesses around the world! To start selling today, sign up for your $1 per month trial at https://Shopify.com/sysk INDEED: Get a $75 sponsored job credit to get your jobs more visibility at https://Indeed.com/SOMETHING right now! QUINCE: Stick to the staples that last, with elevated essentials from Quince! Go to https://Quince.com/sysk for free shipping on your order and 365 day returns! HERS: Hers is transforming women's healthcare by providing access to affordable weight loss treatment plans, delivered straight to your door, if prescribed. Start your initial free online visit today at https://forhers.com/something DELL: The Black Friday in July event from Dell Technologies is here. Upgrade for a limited-time only at https://Dell.com/deals Learn more about your ad choices. Visit megaphone.fm/adchoices
John Tregoning is a leading immunologist, researcher, and author, dedicated to making the complex world of science accessible to everyone. He is the author of Live Forever?: The Curious Scientist's Guide to Wellness, Ageing and Death in which he explores aging and what we can do about it. He previously published Infectious: Pathogens and How We Fight Them, which describes the history and science of infectious disease.As a professor at Imperial College London, John specializes in vaccine immunology, focusing on how the body defends itself against infectious diseases.Follow To Dine For:Official Website: ToDineForTV.comFacebook: Facebook.com/ToDineForTVInstagram: @ToDineForTVTwitter: @KateSullivanTVEmail: ToDineForTV@gmail.com Thank You to our Sponsors!American National InsuranceWairau River WinesFollow Our Guest:Official Site: Dr. John TregoningInstagram: @A_Curious_ScientistLinkedIn: John TregoningFollow The Restaurant:Official Website: The Hidden Hut - Cornwall, EnglandFacebook: The Hidden HutInstagram: @HiddenHut Hosted on Acast. See acast.com/privacy for more information.
'n Nuwe studie het bevind dat die ernstige Europese hittegolf van 23 Junie tot 2 Julie vanjaar na raming 2 300 sterftes in 12 stede veroorsaak het. Dit is volgens die studie deur Imperial College London en die London School of Hygiene and Tropical Medicine. Van die sterftes word sowat tweederdes toegeskryf aan aardverwarming, met 88 persent van die slagoffers ouer as 65. 'n Omgewingsepidemioloog, Pierre Masselot, het aan The Independent gesê die wêreld moet ophou om fossielbrandstowwe te verbrand:
Một nghiên cứu mang tính bước ngoặt từ Imperial College London đã quy - 1.500 ca tử vong trong đợt nắng nóng ở châu Âu tuần trước - cho biến đổi khí hậu do con người gây ra.
A landmark study from Imperial College London has attributed 1,500 deaths during last week's European heatwave directly to human-induced climate change. It's the first rapid attribution study to go beyond linking climate change to weather events, and instead ties it directly to human deaths.
Die onlangse rekord-hittegolf in Europa het die dood van 2 300 mense veroorsaak, volgens 'n wetenskaplike studie. Die studie het 12 stede ondersoek en bevind dat sowat 1 500 van die sterftes toegeskryf kan word aan die uitwerking van klimaatsverandering. Friederike Otto, 'n professor in klimaatswetenskap aan die Imperial College London, het meegewerk aan die verslag en sê dit onderstreep die behoefte aan verandering.
‘Heatwaves are silent killers', according to Dr Gary Konstantinoudis, lecturer at the Grantham Institute for Climate Change and the Environment, at Imperial College London.Summer heatwaves caused 263 deaths in London. This data comes as a week-long heat health alert for the capital kicks in.A new generation of foldable phones has been unveiled by Samsung.The CEO of X, Linda Yaccarino, has resigned.And chimpanzees have been observed copying quirky social behaviours from one another, even though they offer no apparent practical benefit.For more, we spoke to senior author Dr. Jake Brooker from the Department of Psychology at the University of Durham. Also in this episode: -Microsoft Outlook users have reported issues using the platform-AI surgery could be trialled on humans within a decade-Why cats prefer predictable outcomes instead of surprising events Hosted on Acast. See acast.com/privacy for more information.
Timestamps:3:30 - Teaching a made-up course on London Business School13:29 - Should we be wary of AI?16:00 - It's never been easier to hack software27:38 - Gandalf came out of a hackathon38:38 - Differences between the US and SwitzerlandThis episode was sponsored by infinity.swiss, Switzerland's most advanced AI accounting tool. Save 25% by entering code SWISSPRENEUR at checkout.Click here to order your copy of “Swiss Startups” today.About David Haber:David Haber is the co-founder and CEO at Lakera AI, a real-time GenAI security company. He holds a MEng in Computer Science from Imperial College London and founded Cognitir, a startup providing in-person and on-demand AI education for Fortune 500 companies and world-leading universities, before co-founding Lakera AI in 2021. Co-founded by former Google, Meta, and aerospace engineers, Lakera's team combines cutting-edge AI research with real-world expertise in deploying AI systems that can't fail — at the scale of a billion flight hours. Lakera's mission is to enable enterprises to focus on building the most exciting AI applications securely by protecting them in the world of AI cyber risk.To accelerate secure adoption of AI, the company created Gandalf, an educational platform where more than one million users have learned about AI security. Lakera uses AI to continuously evolve defenses, so customers can stay ahead of emerging threats.The cover portrait was edited by www.smartportrait.io.Don't forget to give us a follow on Instagram, Linkedin, TikTok, and Youtube so you can always stay up to date with our latest initiatives. That way, there's no excuse for missing out on live shows, weekly giveaways or founders' dinners.
The actor recently posted a photo of himself undergoing a £10,000 procedure at a London clinic that claims to remove microplastics, forever chemicals and herbicides from the blood. But how settled is the science around the health risks of microplastics? To find out, Ian Sample speaks to Dr Stephanie Wright, associate professor of environmental toxicology at Imperial College London's school of public health. She explains what we know so far about the effects of microplastics in the body, why the science is still evolving, and what we can do to reduce our exposure. Help support our independent journalism at theguardian.com/sciencepod
Today's episode features guest host Michael Upshall (guest editor, Charleston Briefings) who talks with Stephen Webster, Director, Science Communication Unit, Imperial College, London. Stephan began his career by studying biology and the life sciences and attended Cambridge University where he studied the philosophy of science, and became interested in how science is understood and taught. He spent several years as a secondary school science teacher in London and eventually led one of the first science communication master's programs, and is currently a senior lecturer at Imperial College. Stephen believes that engaging and listening to the public is very important with science communication to build trust, and to see the public as partners who could be very knowledgeable. He also says that good science is built on well-supported scientists. The video of this interview can be found here: https://youtu.be/yG6kJtvfx7A Social Media: LinkedIn: https://www.linkedin.com/in/mupshall/ https://www.linkedin.com/in/stephen-webster-36723853/ Twitter: Keywords: #SciComm, #ScienceCommunication #PublicEngagement #ScienceEducation #HigherEducation #OpenScience #ResearchCulture #EthicsInScience #CommunityEngagement #LibraryInnovation #Innovation #LibraryJobs #career #collaboration #scholcomm #ScholarlyCommunication #libraries #librarianship #LibraryNeeds #LibraryLove #ScholarlyPublishing #AcademicPublishing #publishing #LibrariesAndPublishers #podcasts
This is the latest episode of the free DDW narrated podcast, titled "UK Spotlight: Innovation and discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “Where is the drug discovery expertise happening in the UK?”, “From the top: Dr Martin Main, Medicines Discovery Catapult”, and “Meet the Researcher: Molly Stevens, Oxford University and Imperial”. In the first article, I highlight the research taking place and where this is happening in the UK, a long-established hub for drug discovery expertise worldwide. In the second article, I spoke with Dr Martin Main, Chief Scientific Officer, Medicines Discovery Catapult, in the From the Top series. In the third article, I spoke with Molly Stevens, John Black Professor at Oxford University and Research Director for Biomedical Materials at Imperial College London, as part of the Meet the Researcher series.
In an interview last weekend, Iran's ambassador to the UN said his country's nuclear enrichment ‘will never stop' because it is permitted for ‘peaceful energy' purposes. It is the latest development in an escalation of tensions over Iran's nuclear programme, which erupted when Israel targeted the country's nuclear facilities in June. To understand why enrichment is so important, Madeleine Finlay talks to Robin Grimes, professor of materials physics at Imperial College London. He explains what goes into creating a nuclear weapon, and why getting to the stage of weaponisation is so difficult. Help support our independent journalism at theguardian.com/sciencepod
This is a special episode I recorded in collaboration with Joe Moore from Psychedelics Today at the largest conference in the field "Psychedelic Science 2025" in Denver last week. It very early in the morning, at 8am, and it was fabulous. Our guests: Tommaso Barba, Neuroscientist from Imperial College London and Dee Dee Goldpaugh, therapist, author and clinical consultant, me and Joe were talking about Sex, Intimacy and Psychedelics! Check out this episode, it's fun and very insightful.IG: @Tommaso.barba @deedeegoldpaugh @psychedelicstoday Hosted on Acast. See acast.com/privacy for more information.
A technology transfer expert and biotech spin-out founder explain the steps involved in moving discoveries from the lab to the market. Most academics want their work to have an impact and one route to achieving this is by commercialising their findings. By partnering with an existing company to bring a product to market or by establishing a new spin-out enterprise, scholars can develop technologies, products and solutions that can revolutionise whole sectors, whether in healthcare, construction, farming and more. But this is a far from easy or simple process requiring tenacity, adaptability, collaboration and high level problem solving. For this week's podcast, we speak to two people with extensive experience in what it takes to commercialise research and become an academic entrepreneur. Mairi Gibbs is CEO of Oxford University Innovation – the university's technology transfer unit - where she has worked since 2002. With extensive practical experience in partnership management, formation of spinout companies, licensing and patent portfolio management, she explains the initial steps to commercialisation, what investors look for and what can be done at an institutional level to support more spin out activity. Andrew Hammond is co-founder and head of R&D at Biocentis – an Imperial College London spin out founded in 2022. With a background in molecular biology, Andrew's 10-year academic career at both Imperial and Johns Hopkins University involved advancing gene editing technology for use in insects. The resulted in the development of gene drive technology designed for use on malaria mosquitos and the later development of Biocentis. For more advice and insight on this topic, read our spotlight guide on how to work well with industry.
Veja o vídeo em expresso.pt/podcasts/45-graus Luís M. A. Bettencourt é físico, professor na Universidade de Chicago, e um dos investigadores mais reputados a nível mundial na ciência dos sistemas complexos, sobretudo aplicados ao estudo das cidades. Licenciou-se em Engenharia Física pelo Técnico, em Lisboa, obteve o doutoramento em Física Teórica no Imperial College London e acabou por se dedicar à investigação na Biologia evolutiva e na chamada “ciência urbana” É actualmente professor na Universidade de Chicago, de Ecologia e Evolução, onde é também membro associado do Departamento de Sociologia e Professor Externo no Santa Fe Institute. A nível de investigação, destacou-se sobretudo por desenvolver teoria quantitativa e preditiva da dinâmica urbana, ao identificar leis de escala que ligam a dimensão da população de uma cidade à sua infraestrutura, inovação, riqueza e criminalidade, juntamente com autores como Goffrey West (autor de um livro de 2017 “Scale” precisamente sobre estes temas). _______________ Bilhetes para o 45 Graus ao vivo _______________ Índice: (0:00) Início (5:00) O que são Sistemas Complexos; percurso do convidado (24:12) Porque há cada vez mais pessoas a viver em cidades? (27:37) Paralelos entre Biologia e Urbanismo | Lei de Zipf (35:10) Esta Ciência ajuda-nos a compreender a evolução das cidades e dos países? (50:49) Leis de “scaling” nas cidades (58:04) Leis de velocidade de crescimento das cidades (1:00:31) Pode esta Ciência ajudar-nos a resolver problemas colectivos? | Habitação: o caso de Viena. O caso de Singapura | Livro sobre emergência da democracia em Atenas (1:12:57) História: o que explica que alguns países melhorem e outros piorem? (1:29:03) Internet e redes sociais: Why the Internet Must Become More Like a City (1:34:53) De que precisamos para criar uma Silicon Valley na Europa? | O caso de Israel.See omnystudio.com/listener for privacy information.
Khalid Saad is a seasoned venture capitalist and FinTech entrepreneur with a proven track record of launching new ventures and accelerating existing ones. Over the years, he has partnered with startups and established companies on digital strategy, business development, partnerships, and market-entry plans—spanning payment systems, remittance services, crypto platforms, open banking, and more .He is the Founder & Managing Partner of Bunat Ventures, a Bahrain-based regulated venture-builder VC focused on nurturing and investing in high-growth startups across the GCC.Khalid serves on the board of CoinMENA, a Central Bank–regulated crypto-asset exchange, and is a board member of Oqal – Bahrain Chapter, the region's largest and most active angel investment network . Additionally, he advises 01 Systems, a leading regional financial technology and digital transformation firm, and contributes to the Finance, Insurance & Tax Committee of the Bahrain Chamber.Until recently, Khalid was the Founding CEO of Bahrain FinTech Bay (BFB)—the largest FinTech hub in MENA, recognized by S&P Global Ratings as one of the region's two most advanced FinTech ecosystems . Under his leadership, BFB united ~100 public and private stakeholders (regulators, banks, telcos, asset managers, family firms, educational institutions, etc.) and hosted around 50 companies working across payments, blockchain, crypto assets, data analytics, robo-advisory, crowdfunding, and AI .Before BFB, Khalid was a Business Development Manager at the Bahrain Economic Development Board, where he promoted the financial services sector and attracted major institutions—from banks and wealth managers to FinTechs and insurers—to Bahrain . Prior to that, he worked with Ernst & Young, conducting feasibility studies, market research, and implementing a governance, risk & compliance platform in Bahrain, and with SEI Investments in London managing UK and European equity portfolios .Khalid holds an MSc from Imperial College London and a First Class BSc from the University of Exeter .LinkedIn: https://www.linkedin.com/in/khalidesaad/
Several Australian universities have earned spots among the world's top 100 in two surveys — the US News and QS Global Rankings. Leading the charts are US institutions like the Massachusetts Institute of Technology, Stanford, and Harvard, while UK universities such as Cambridge, Oxford, and Imperial College London continue to hold strong positions. A global rankings expert weighs in if these rankings matter, especially for international students considering their options.
With the blistering temperatures that most of India is suffering under, it should come as no surprise that May 2025 was the second-warmest month of May since records began. But what is of greater concern now, is how this heat is going to affect our future generations -- a new study has found that India recorded an average of six additional days of dangerously high temperatures for pregnant women every year over the last five years. What is this extreme heat doing the bodies of mothers to be? How does heat affect pregnancy outcomes? What will it mean for the near future, as India continues to experience heat waves? Guest: Prof Jane Hirst Chair in Global Women's Health, The George Institute for Global Health, Imperial College London and Visiting Professor in Global Women's Health, University of Oxford Host: Zubeda Hamid Edited by Sharmada Venkatasubramanian Learn more about your ad choices. Visit megaphone.fm/adchoices
ICYMI, I'll be in London next week, for a live episode of the Learning Bayesian Statistics podcast
Imagine we could have a digital version of our entire body which could help us, and our doctors, decide what life style is good for us, predict which diseases we might get, and how to best treat them? In short, what if we could all have our very own digital twin? The idea isn't quite as sci-fi as it sounds. A gigantic scientific effort called the Physiome Project is about piecing together a mathematical description of the entire physiology of the human body. Once this has been achieved to a sufficient level digital twins will be a spin-off. In this podcast we revisit an interview we did back in 2019 with Steven Niederer, who was then Professor of Biomedical Engineering at King's College London but has since moved to a new position at Imperial College London as Chair of Biomedical Engineering. Niederer told us about the physiome project, about how the fitbits many of us own are a very first step towards a digital twin, and about how you can model individual human organs such as the heart. We also challenge ourselves to explain differential equations in one minute. You can find out more about maths and medicine, differential equations and mathematical modelling on Plus. We met Niederer in 2019 when he helped to organise a research programme at the Isaac Newton Institute for Mathematical Sciences in Cambridge. The music in this podcast comes from the artist Oli Freke. The track is called Space Power Facility. This podcast forms part of our collaboration with the Isaac Newton Institute for Mathematical Sciences (INI) – you can find all the content from the collaboration here. The INI is an international research centre and our neighbour here on the University of Cambridge's maths campus. It attracts leading mathematical scientists from all over the world, and is open to all. Visit www.newton.ac.uk to find out more.
Claudia de Rham has rather an unusual relationship with gravity. While she has spent her career exploring its fundamental nature, much of her free time has involved trying to defy it - from scuba diving in the Indian Ocean to piloting small aircraft over the Canadian waterfalls. Her ultimate ambition was to escape gravity's clutches altogether and become an astronaut, a dream that was snatched away by an unlikely twist of fate. However, Claudia has no regrets - and says defying gravity for much of her life has helped her to truly understand it. As Professor of theoretical physics at Imperial College London, she now grapples with deep mathematics, where the fields of particle physics, gravity and cosmology intersect, on a quest to understand how the universe really works. She is a pioneer of the theory of massive gravity, a theory which could take us beyond even Einstein's theory of relativity and shed light on why the universe is expanding at an ever-increasing rate.Presented by Jim Al-Khalili Produced by Beth Eastwood
Message our hosts, Kieran and Jose.Our Animal Heartbeat live panel discussion in 2025 covers the topic of artificial intelligence and its use in veterinary and human patients. Our panel review topics such as how to validate AI tools, where AI fits in current medicine and how opportunities for its use are evolving, and should we worry about AI?Our hosts Kieran and Jose are joined by a fantastic panel of guests:Professor Virginia Luis Fuentes; Professor of Veterinary Cardiology, Royal Veterinary CollegeProfessor Anurag Agarwal; Professor of Aeroacoustics, University of CambridgeDr Matthew Shun-Shin; Consultant Cardiologist, Imperial College LondonCatherine Stowell; Imperial College London and founder of The Animal Ultrasound AssociationThis episode was recorded live at Emmanuel College, Cambridge, as part of the 2025 Cambridge Festival of podcasts.
Daniel M. Davis is a world-renowned immunologist and Professor Immunology at Imperial College London. He is an acclaimed author and researcher and released his latest book ‘Self Defence: A Myth-busting Guide to Immune Health' on 5th June 2025.In part one, Dan joins Dr Alex George to unpack the endless myths we hear about our immune health, how stress can impact our immune system and reveals how much of our immune health is actually predetermined by genetics.Plus, Dan discusses the ways in which the immune system can fight off cancer and why it's so important to be skeptical of anything that sounds ‘too simple' when talking about immune health…Buy Dan's latest book ‘Self Defence: A Myth-busting Guide to Immune Health' through our affiliate bookshop and you'll help fund Stompcast by earning a small commission for every sale. Bookshop.org's fees help support independent bookshops too!Follow the podcast on Instagram @thestompcastGet the new, pocket guide version of The Mind Manual nowDownload Mettle: the mental fitness app for men Hosted on Acast. See acast.com/privacy for more information.
In this episode, Robin Carhart-Harris, PhD joins to elucidate the intersection of psychedelics and neuroplasticity. Dr. Carhart-Harris is the Ralph Metzner Distinguished Professor in Neurology and Psychiatry at the University of California, San Francisco. Robin founded the Centre for Psychedelic Research at Imperial College London in April 2019, was ranked among the top 31 medical scientists in 2020, and in 2021, was named in TIME magazine's ‘100 Next' – a list of 100 rising stars shaping the future. Dr. Carhart-Harris begins by discussing the impact of psychedelics on neuroplasticity and mental health. He explains neuroplasticity as the brain's ability to change, emphasizing its role in mood disorders and substance use and describes how stress atrophies the brain, leading to mental illness. Dr. Carhart-Harris differentiates between neuroplasticity and neurogenesis, noting that while neurogenesis is limited in adults, neuroplasticity can be influenced by psychedelics like ketamine, psilocybin, and MDMA. In closing, he also discusses the entropic brain hypothesis, suggesting that increased brain entropy leads to richer subjective experiences. In this episode, you'll hear: The relationship between neuroplasticity and “canalization” Why homeostatic neuroplasticity may promote mental wellbeing Differences between ketamine, MDMA, and serotonergic psychedelics in terms of neuroplasticity The details of the entropic brain hypothesis Psychedelics' effect on the default mode network The frontiers of research into psychedelics and neuroplasticity Quotes: “So changeability is what plasticity is. And neuroplasticity—that's the ability of the brain to change. Okay, and how is neuroplasticity related to mood disorders like depression and anxiety or substance use disorder or something like that? Well, that's a great question cause we don't have it entirely nailed down. But one of the most reliable findings in biological psychiatry is that stress atrophies the brain.” [2:47] “The main thing with ketamine is that the window of increased plasticity is brief… That makes sense because that reflects how ketamine seems to work therapeutically—that it provides relief somewhat short-term, unless it is twinned with, say, psychotherapy or you do repeat administration and get someone out of the rut they were in.” [22:15] “We've seen in people with depression, brain networks can become quite segregated from each other—they are ordinarily, they're quite functionally separate and distinct—but that modularity might be a bit elevated in depression. But what we've seen with psilocybin therapy is that separateness between systems, that segregated quality of organization of brain networks, brain systems actually decreases after psilocybin therapy for depression. I'll put it another way: the brain looks more globally interconnected after psilocybin therapy for depression and the magnitude of that… correlates with improvements.” [39:19] Links: Carhart-Harris Lab website Dr. Carhart-Harris on X Dr. Carhart-Harris' 2025 article: “Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models” Dr. Carhart-Harris' 2012 article: “Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin” Dr. Carhart-Harris' 2010 article with Karl Friston: “The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas” Psychedelic Medicine Association Porangui
40 years ago scientists in Antarctica discovered a hole in the Ozone layer. The world acted quickly, phasing out harmful CFCs or chlorofluorocarbons. Evidence suggests the hole has been getting smaller. But in 2025, there are new pollutants threatening to slow progress. Eloise Marais is Professor of Atmospheric Chemistry and Air Quality at University College London and tells Victoria Gill about her work monitoring the impact of space travel on the Ozone layer.It's the first day of the traditional ‘bathing season' when wild swim spots are regularly tested throughout the UK summer. Victoria asks Professor of Environmental Microbiology and Health at Lancaster University, Roger Pickup to break down the science behind our water quality classifications. And May also means wildflowers. Dr Sarah Scott is pollinator ecologist and toxicologist at Cambridge university. She has a warning that planted in the wrong place, wildflowers could be harming bumble bees.Gareth Mitchell, broadcaster and lecturer in science communication at Imperial College London is in the Inside Science studio to bring Victoria new scientific findings which will shape our future.Presenter: Victoria Gill Producers: Clare Salisbury, Dan Welsh, Jonathan Blackwell Editor: Martin Smith Production Co-ordinator: Jana Bennett-Holesworth
ZOE's menopause research shows that perimenopause and menopause symptoms can be reduced through nutrition. Thousands of women took part in their research and the findings show that changing food habits may reduce the chance of having a particular menopause symptom by up to 37% for some women, and this includes women taking HRT. It's no surprise that what you eat can impact how you feel In this interview you'll learn more about the research and specific food and lifestyle modifications that make a difference. My two guests are: Dr. Federica Amati, who works as Head Nutritionist for science and nutrition company, ZOE and holds a PhD in Clinical Medicine Research from Imperial College London, has a masters in Public Health and is an Association for Nutrition (AfN) accredited Nutritionist. Alongside her research and nutrition work, Federica has written two books, Recipes for a Better Menopause and Every Body Should Know This, which was recently released in the UK. Sarah Berry is a Professor at King's College London and has run more than 35 human nutrition studies. Notably, she is the Chief Scientist at ZOE, the science and nutrition company. She's the lead nutritional scientist for the ZOE PREDICT study — the world's largest in-depth nutritional research program and leads research across menopause, microbiome and sleep. This is a deep dive into how to use nutrition to manage menopausal symptoms so be sure to share it with your friends! RESOURCES MENTIONED JOIN MICHELE'S NEWSLETTER + Receive A Free Curated List of 52 Self-care Tips Michele on IG GUEST INFORMATION Website: zoe.com/menoscale Instagram: Zoe Sarah on IG Federica on IG If you enjoyed this interview, please take a moment to rate and review it on Apple podcasts. Your reviews are so appreciated! Not sure how to do it? Instructions are below. XO, Michele Rate + Review: 1. Click on this link 2. Click “View in iTunes” button 3. Click “Subscribe” button 4. Click “Ratings and Reviews” text 5. Click to rate and leave short review and you're done!
We're following up on our recent episode on Google's AI Co-Scientist with a special crossover episode from the Podovirus podcast. Hosts Dr Jessica Sacher and Dr Joe Campbell speak with José Penadés and Tiago Costa, scientists at Imperial College London who made a surprising discovery that Google's AI Co-Scientist later put forward as a hypothesis entirely on its own. The episode explores the fascinating world of bacteriophages (viruses that infect bacteria) and phage-inducible chromosomal islands (PICIs) - DNA sequences that hijack virus reproduction to spread themselves as a bacterial defense mechanism. The key mystery was how capsid-forming PICIs, which only encode virus heads without tails, managed to spread across different bacteria. The surprising answer, which eluded human scientists for years but which Google's AI Co-Scientist discovered through literature analysis, is that these capsids evolved to connect with various virus tails in the environment. This episode demonstrates how AI can now contribute to frontier scientific research beyond just grunt work - providing unbiased perspectives and key insights that accelerate discovery. It's a vivid example of science fiction becoming reality in our lifetimes. SPONSORS: Oracle Cloud Infrastructure: Oracle Cloud Infrastructure (OCI) is the next-generation cloud platform that delivers better, cheaper, and faster solutions for your infrastructure, database, application development, and AI needs. Experience up to 50% savings on compute, 70% on storage, and 80% on networking with OCI's high-performance environment—try it for free with zero commitment at https://oracle.com/cognitive NetSuite by Oracle: NetSuite by Oracle is the AI-powered business management suite trusted by over 41,000 businesses, offering a unified platform for accounting, financial management, inventory, and HR. Gain total visibility and control to make quick decisions and automate everyday tasks—download the free ebook, Navigating Global Trade: Three Insights for Leaders, at https://netsuite.com/cognitive Shopify: Shopify powers millions of businesses worldwide, handling 10% of U.S. e-commerce. With hundreds of templates, AI tools for product descriptions, and seamless marketing campaign creation, it's like having a design studio and marketing team in one. Start your $1/month trial today at https://shopify.com/cognitive PRODUCED BY: https://aipodcast.ing CHAPTERS: (00:00) About the Episode (04:37) Welcome to Podovirus Podcast (04:58) Introducing the Special Guests and Topic (06:30) Exploring Mobile Genetic Elements (13:20) The Role of AI in Phage Research (16:48) Mechanisms of Gene Transfer (Part 1) (20:10) Sponsors: Oracle Cloud Infrastructure | NetSuite by Oracle (22:43) Mechanisms of Gene Transfer (Part 2) (23:36) Insights and Discoveries (28:45) Future Directions and Applications (Part 1) (32:35) Sponsors: Shopify (34:32) Future Directions and Applications (Part 2) (41:22) Unbiased Systems and Conjugation (42:35) Google's Excitement and Experimental Evidence (45:39) Benchmarking AI Systems (49:29) Manuscript Revisions and Future Plans (51:53) AI as a Collaborator in Scientific Research (54:52) Challenges and Hypotheses in Phage Biology (57:58) Future of AI in Scientific Research (01:05:52) Concluding Thoughts and Future Collaborations (01:12:07) Outro
Michael Ringel is the Chief Operating Officer of Life Biosciences, a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. Michael became COO of Life just a few months ago, but he's been advising the company since 2018. Prior to this year, he was managing director and senior partner at Boston Consulting Group (BCG), where over a 25-year career he focused on R&D and innovation initiatives across the private sector and government. He earned his PhD in biology at Imperial College London and a JD from Harvard Law, and has become an active and highly respected member of the global longevity biotech community.In this episode, Chris and Michael explore Life Biosciences' groundbreaking approach to partial epigenetic reprogramming - the "holy grail" technology that could transform how we age at cellular, tissue, and organism levels. They discuss how this approach taps into the same biology that makes babies young, Life's lead therapeutic candidate ER-100 for eye diseases, and the "pipeline in a pill" concept at the core of the geroscience hypothesis: the idea that enable single interventions based on longevity science could treat multiple age-related diseases simultaneously.The Finer Details:The biology behind partial epigenetic reprogramming and how it differs from full reprogramming to pluripotencyWhy Michael considers partial reprogramming the "holy grail" of longevity interventionsLife Biosciences' lead candidate ER-100 for glaucoma and NAION (non-arteritic anterior ischemic optic neuropathy)The innovative inducible system that allows the therapy to be turned on and off with doxycyclineWhy the eye represents an ideal starting point for reprogramming therapiesThe "pipeline in a pill" concept and geroscience hypothesis - how single interventions could treat multiple age-related diseasesParallels between the emerging longevity field and the massive GLP-1 drug market that many pharma companies missedThe role of philanthropic investment in advancing fundamental longevity researchEvolutionary theories of aging and why aging should be easily manipulableTimeline expectations for moving from single disease treatments to whole-body rejuvenationLinksLife Biosciences company websiteMichael Ringel's ARDD talk
We are delighted to host Sarah Tilley on the Mangu.tv podcast. Sarah is a healthcare entrepreneur, psychedelic guide and founder of a Dutch-based legal psychedelic company, Beautiful Space. She is the creator of the Beautiful Space Method of Relational Therapy, a new model of psychedelic-assisted therapy, resetting couples and individuals addressing loss of desire in romantic relationships. A mother, healer, educator and musician, Sarah has been working with plant medicine and altered states for over 20 years. Originally trained in alternative medicine, she most recently studied with Esther Perel and Betty Martin.An advocate for healthcare equality and safe psychedelics, Sarah continues to build a legacy of research, ethics, therapy and training programs contributing to the emerging field of psychedelic wellness. Beautiful Space is in collaboration with Imperial College London on the first study on psilocybin, couples and relationship wellbeing with psychological support.Sarah shares the story of her upbringing in the greenbelt of the UK, where music provided solace amidst a challenging environment. She speaks about her early curiosity in spirituality, lucid dreaming and philosophy, and her journey into the world of plant medicine. Sarah shares the struggles of her divorce and the effects of divorce on children, as well as her work in psychedelic-assisted therapy for relationships and as an alternative to divorce. Giancarlo and Sarah discuss sexuality, pleasure, and Sarah's introduction to working with sexuality. They discuss psychedelic-assisted therapy for couples, they delve into consent, non-monogamy and the intricacies of both in the modern-day world.
Have you ever wondered how much of your success is down to luck? What if the world is far less fair and predictable than we'd like to think? On this episode, I explore the complex and fascinating role of luck in our lives and decisions with Dr. Chengwei Liu, Associate Professor of Strategy and Behavioural Science at Imperial College London. Chengwei shares how his research challenges our assumptions about skill, effort, and fairness – and why the outcomes we see are often far more random than we'd like to believe. We discuss why many successful strategies and best practices are built on shaky ground, and how our tendency to downplay luck creates illusions of control and reinforces unfair systems. Chengwei explains how beliefs in fairness – like the ‘just world' hypothesis – shape everything from business cultures to political systems, and how luck and misperceptions of it can create cycles of privilege or disadvantage. Chengwei also shares practical insights on how to become a smart contrarian: someone who can harness the power of randomness and serendipity while avoiding the pitfalls of bias and overconfidence. From the dangers of blindly following the ‘successful' to the need to look inward and embrace uniqueness, it's a thought-provoking conversation that will change the way you think about risk, decision-making, and what it really means to get ahead. Guest BiographyDr. Chengwei Liu is an Associate Professor of Strategy and Behavioural Science at Imperial College London. He describes himself as someone fascinated by how luck, randomness, and human biases shape success and failure – both in business and in broader society. Chengwei's work challenges mainstream management thinking and explores how much of what we attribute to skill is actually the result of random factors. His book, Luck: A Key Idea for Business and Society, examines these dynamics and how we can learn to navigate them. Beyond his academic roles, Chengwei has also worked as a management consultant, drawing on his experience in both research and practice to uncover how to harness luck and uncertainty. AI-Generated Timestamped Summary[00:00:00] Introduction[00:02:00] Chengwei explains his research focus on randomness and variance in firm performance [00:04:00] The overlooked 50% of variance in outcomes: luck and randomness [00:06:00] Defining luck as what lies beyond our control and foresight [00:08:00] The conflict between fairness beliefs and the reality of luck [00:10:00] Luck's societal implications: why fairness perceptions differ across countries [00:11:00] Skill versus luck – how we confuse the two in our narratives [00:13:00] Why successful people over-attribute their success to skill [00:15:00] Managers vs entrepreneurs: how they differ in acknowledging luck [00:17:00] The challenges of researching an elusive concept like luck [00:18:00] Using mathematical models to understand Black Swan events [00:20:00] Why successful predictions of Black Swan events don't indicate forecasting skill [00:23:00] The problem with best practices from ‘successful' firms [00:26:00] Selection bias in business books and the danger of survivor bias [00:29:00] The ‘too good to be true' heuristic as a guide [00:31:00] Contrarian thinking as a survival strategy for uncertainty [00:33:00] The replication crisis and the problem with social science predictability [00:35:00] Human curiosity: the power of moderate surprises [00:37:00] The difference between luck and serendipity [00:39:00] How to encourage serendipity in our lives [00:41:00] Embracing uniqueness and avoiding conformity [00:44:00] Lessons for the age of AI and human creativity [00:46:00] The dangers of ignoring randomness: when biases become destructive [00:48:00] Exploiting others' biases for strategic advantage [00:50:00] Why ‘smart contrarian' thinking is more important than ever [00:53:00] Testing contrarian ideas like a scientist [00:56:00] The limits of trial and error: learning from mistakes [00:58:00] Chengwei's ongoing research: minority decision-making in venture capital [01:00:00] How passion and variance link to VC investment strategies [01:02:00] Wrapping up with reflections on luck, curiosity, and human creativity LinksDr. Chengwei Liu's book, Luck: A Key Idea for Business and Society: https://www.routledge.com/Luck-A-Key-Idea-for-Business-and-Society/Liu/p/book/9781138094260? Chengwei Liu's Imperial College faculty webpage: https://profiles.imperial.ac.uk/c.liu
Listener Christine wants to understand one of the strangest phenomena in the universe. But to get to grips with it, she'll need a crash course in the bizarre behaviour of the very small. Here, things don't act the way you might expect — and it's famously hard to wrap your head around. Anand Jagatia has assembled some of the sharpest minds in the field and locked them in a studio. No one's getting out until Christine and Anand know exactly what's going on. Or at least, that's the plan. On hand to help are Kanta Dihal, lecturer in science communication at Imperial College London; James Millen, King's Quantum Director at King's College London; and particle physicist Harry Cliff from the University of Cambridge. Prepare to enter the world of the very small—and the very weird—where particles can be in two places at once, influence each other across vast distances, and seem to decide what they are only when observed. Hear how these once-theoretical oddities are now driving a technological revolution, transforming everything from computing to communication. Presenter: Anand Jagatia Producer: Harrison Lewis Series Producer: Ben Motley
We are excited to host Tommaso Barba for this episode on the Mangu.tv podcast series. Tommaso Barba is a PhD candidate at the Centre for Psychedelic Research, Imperial College London, exploring the brain effects of short-acting psychedelics such as DMT and 5-MeO-DMT. Under the supervision of Dr. David Erritzoe, Prof. David Nutt and Dr. Chris Timmermann, his work focuses on the potential to treat depression and enhance well-being. He authored the first scientific paper on psychedelics on sexual functioning, published in Nature Scientific Reports and compared psilocybin to antidepressants. With a background in neuroscience and psychoanalysis from Maastricht University, Tommaso also investigates psychedelics' impact on romantic intimacy. A passionate science communicator, he engages audiences via LinkedIn and X.Tommaso shares the story of his upbringing in Bologna, Italy. He speaks about his fascination with psychoanalysis from a young age, his early confusion with sexuality, and rise in popularity due to his social media presence. He speaks about his disenchantment with the world he was in, and the superficiality of some of his relationships, as well as the cathartic moment, and subsequent fascination in mind and altered states. Giancarlo and Tommaso discuss expanded states and the mind's capacity to go beyond the subconscious. They speak about holotropic breathwork, the internal family system, and the varying acceptance of wisdom and madness depending on perspective and place. Tommaso shares upcoming and current projects, and speaks about his various trials with psychedelics, relationships and the mind, at Imperial College London.
This spring, are you bombarded by wellness trends promising miraculous results? From detox juices to the surprising popularity of beef tallow, it's easy to get swept up in the hype. But what if some of these "healthy" habits are doing more harm than good? Join us as we dive into the science behind spring's most talked-about health fads. To explain these trends, journalist, health entrepreneur and bestselling author Liz Earle, joins us to share insights from her 40 year career in the wellness industry. Alongside Liz is Dr. Federica Amati, a scientist from Imperial College London, ZOE's Head Nutritionist, and author of the bestseller "Every Body Should Know This." Together, we'll put five popular trends under the microscope: detox drinks, red light therapy, beef tallow for skin, creatine, and high-cost probiotics. Discover what's fact and what's fiction, empowering you to make evidence-based choices. Finally, we'll share practical ZOE-approved tips for embracing spring with genuine, science-backed wellness strategies, helping you navigate the season of renewal with confidence.
Even if I needed two to three allergy medications. For over 6 years! And looked like something from a horror movie due to my allergies!WAS IT REALLY ALLERGIES - or just symptoms of something else going on? What are allergies? ------------In this episode of BodyHacking – Build a Better You, Michaela opens up about her personal battle with allergies that began after the birth of her second son. From seasonal sniffles to full-blown cross-allergies that made her react to almost every fruit and vegetable, she found herself dependent on multiple antihistamines a day.But what if allergies aren't just allergies? What if they're actually signals that your immune system needs help?Join Michaela as she breaks down:• What allergies really are and why your immune system overreacts• The link between gut health, leaky gut, and food/environmental sensitivities• How heavy metals and nutrient deficiencies contribute to allergic conditions• The role of Omega-3s, beta-glucans, and local bee pollen in calming the immune system• How processed foods and AA buildup can trigger long-term inflammation• Her transformation from histamine overload to a life without symptoms—even in peak pollen seasonThis episode is packed with personal insight, scientific studies, and practical tools for anyone struggling with allergies, asthma, or chronic inflammation.